Telangana Chief Minister Revanth Reddy says he will write to other Chief Ministers, including Chandrababu Naidu, to oppose the UGC draft guidelines.

YSRCP leader V Vijayasai Reddy on Saturday resigned as a member of Rajya Sabha and announced he was quitting politics due to "personal reasons", the fourth party MP to short-terminate their terms ...

YSRCP leader V Vijaysai Reddy on Saturday resigned as a member of the Rajya Sabha citing personal reasons. He met Vice President Jagdeep Dhankhar and submitted his resignation. Vijaysai Reddy ...

YSRCP Rajya Sabha member V Vijayasai Reddy on Friday said he will be resigning from his parliament membership on January 25. In a post on 'X', he said he is not joining any other party and also ...

AUSTIN, TX AND ROUND ROCK, TX / ACCESS Newswire / January 23, 2025 / Venkata Sai Swaroop Reddy, a distinguished expert in artificial intelligence and product design, has achieved transformative ...

Telangana Chief Minister Revanth Reddy discussed the state's investment progress. He aims for projects worth Rs 1 lakh crore this year, highlighting Hyderabad's appeal to global investors and its ...

Pharmaceutical major Dr Reddy's Laboratories is slated to release its October-December earnings report on January 23. Marking a shift from previous quarters of solid growth, the company's net ...

Reddy Customs, an automotive customization company, introduced four vehicle modifications at the Bharat Mobility Global Expo 2025 in New Delhi. The showcase includes a Mercedes G-Wagon, a Mercedes ...

The ‘TelanganaRising’ delegation led by Chief Minister A. Revanth Reddy landed in Zurich, Switzerland on Monday (January 20, 2025) morning after their successful visit to Singapore.

Indian pharmaceutical major, Dr Reddy’s Laboratories, is scheduled to deliver its October-December quarterly earnings for the financial year 2024-25 (Q3FY25) on Thursday, January 23, 2025. According ...

BofA has chosen Dr. Reddy's Laboratories Ltd. as its top pick in the Indian pharma space, as its sees earnings visibility in the near term. Two years of outperformance-boosted valuation and gross ...